Stockreport

Rockland Immunochemicals, Inc. CSO Opines "Benefits of Polyclonal Antibodies" in peer-reviewed article

Bio-Techne Corp  (TECH) 
Last bio-techne corp earnings: 4/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bio-techne.com
PDF LIMERICK, Pa. (PRWEB) August 09, 2018 Rockland Immunochemicals, Inc. announced today that Dr. Carl Ascoli, Chief Science Officer at Rockland, and Dr. Birte Aggeler, Dir [Read more]